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Men who have sex with men (MSM) attending sexual health (SH) clinics are at high-
risk for HIV acquisition and are disproportionately affected by STIs. We collected 
standardised behavioural data from MSM attending clinics to characterise sexual 
behaviours and identify predictors for HIV and sexually transmitted infections (STI).  
In 2012-2013, HIV-negative MSM attending five SH clinics in England reported 
sexual behaviours in the previous three months via a self-administered 
questionnaire. Behaviours were linked to the individual’s clinical records using 
national surveillance. The prevalence and incidence of bacterial STIs (gonorrhoea, 
chlamydia, lymphogranuloma venereum and syphilis) and incidence of HIV were 
calculated. Adjusted odds ratios and hazard ratios with 95%CI reported for 
significant predictors. Of 1,278 HIV-negative MSM, 54% were of white ethnicity and 
UK-born and 43% were 25-34 years old. Almost all men reported at least one partner 
in the last three months. Half reported condomless anal sex and 36% condomless 
receptive anal intercourse (CRAI). Incidence of bacterial STIs was 46/100 (95%CI 
39-54) person years and of HIV was 3.1/100 (95%CI 1.7-5.6) person years. A STI at 
baseline and CRAI with increasing numbers of partners were associated with both 
incident infections. In this cohort of MSM high-risk behaviours and STIs were 
prevalent. Engagement in CRAI increased the likelihood of subsequent infection, 
while men diagnosed with a bacterial STI were at increased risk of a future STI. 
Clinical and behavioural risk assessments to determine an individual’s risk of 
infection could allow a more nuanced prevention approach that has greater success 




Since the beginning of the HIV epidemic, sex between men has been one of the 
main transmission routes for HIV in the UK. In 2015, 3,320 men who have sex with 
men (MSM) were newly diagnosed with HIV (1); a 24% increase in the last decade. 
Since then, a recent decline in new diagnoses attributed to increased repeat testing 
and treatment as prevention has been observed (2). In 2016, gonorrhoea diagnoses 
among MSM attending sexual health (SH) clinics declined though they continue to 
disproportionally affect MSM, while syphilis has increased (3). MSM attending SH 
clinics are considered to be a higher risk population than MSM who do not. They 
report more risk behaviours (4) and HIV incidence is estimated to be 2/100 person-
years (py) among clinic attending MSM (5) compared to an incidence of less than 
1% in the general MSM population (6, 7). SH clinics are an open-access, free and 
confidential service offering a comprehensive service of testing, diagnosis and care 
for STIs.  
 
Over the last decade, sexual behaviours known to increase the risk of HIV and STI 
transmission have been more frequently reported. Condomless anal intercourse 
(CAI) increased from 46% to 51% between 2000 and 2013 among HIV negative 
MSM from social venues in London (8). Concurrently, there is evidence suggesting 
wider adoption of seroadaptive practices, which are behavioural strategies employed 
to reduce the risk of HIV acquisition (8-10). Common strategies include serosorting, 
where CAI is only practiced with partners of the same HIV status and 
seropositioning, where only insertive CAI is practiced with HIV positive partners. 
Some observers have promoted these practices as a way of reducing HIV 
transmission but there is considerable debate on their effectiveness as success is 
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based on reliable ascertainment of the individual’s and partner’s HIV statuses (10). 
Further, by encouraging men to engage in condomless sex, seroadaptation may also 
inadvertently facilitate STI transmission (11, 12).  
 
The vast majority of sexual behavioural information for MSM in the UK originates 
from community-based cross-sectional studies and internet surveys. While these 
surveys provide rich data on behaviours, their cross-sectional design inherently 
prevents investigation of subsequent clinical outcomes. Though the sexual 
behaviours of MSM attending SH clinics in England are routinely collected in clinics 
(13), the data are neither standardised nor reported. Greater insight into the 
prevalence of sexual behaviours and their role in HIV and STI transmission could be 
established through existing longitudinal national surveillance in SH clinics in 
England. 
 
Our aim was  to characterise self-reported sexual behaviours, identify predictors of 
prevalent STIs and prospectively measure STI and HIV incidence in a cohort of MSM 
who re-attend the same SH clinic to strengthen the evidence base and improve 




A short standardised sexual behavioural questionnaire was developed using existing 
surveys (e.g. Gay Men’s Sexual Health Survey and EMIS) and was further 
discussed by a group of academic, public health and clinical experts.  The 
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questionnaire was tested on a panel of MSM recruited by a community organisation 
(available in Supplementary material). From September 2012 for six months MSM 
(>15 years) not known to be HIV positive were recruited from five SH clinics across 
England;  from Manchester, Brighton, and three from London. In four of the clinics, 
MSM self-completed a paper questionnaire and in the fifth, clinical staff completed 
the questionnaire with men. Self-reported sexual data items included number of 
partners, numbers of unprotected (“condomless” hereafter) anal intercourse (CAI) 
partners, condomless receptive anal intercourse (CRAI) and insertive anal 
intercourse (CIAI) partners in the last three months and HIV status of partners. 
Clinical staff completed the date of attendance and patient ID fields. The patient ID 
was the patient’s unique identification number specific to the clinic, which allows 
patients to be longitudinally followed within (but not across) clinics. No person 
identifiable information was collected.  
 
Data Management 
The sexual behavioural data were linked to clinical outcomes by using the clinic 
name and patient ID to identify clinical records in the Genitourinary Medicine Clinic 
Activity Dataset (GUMCAD). GUMCAD is a mandatory patient-level reporting 
system of all SH clinic attendees in England since 2008 (14). The pseudo-
anonymised dataset contains socio-demographic (age group, ethnicity, area of 
residence) and service use information, which is recorded at each attendance. Once 
participant clinical records were identified in GUMCAD, demographic and clinical 
data pertaining to all retrospective and prospective attendances at the same clinic 






 We reported i) prevalence of sexual behaviours and ii) clinical outcomes among 
MSM. The outcomes measured were (i) prevalence of bacterial STIs newly 
diagnosed at baseline (attendance at which behavioural questionnaire was 
completed) where a bacterial STI was defined as gonorrhoea, chlamydia, 
lymphogranuloma venereum (LGV) and syphilis (primary, secondary and early 
latent), ii) incidence of bacterial STIs and iii) incidence of HIV. To identify incident 
infections, MSM who re-attended the same clinic after baseline were followed from 
baseline until the last attendance occurring before the end of March 2014 or until the 
date of the first bacterial STI or HIV diagnosis; whichever came first. Follow-up visits 
for the same episode of care were excluded. Incidence was expressed per 100 py 
with 95% confidence intervals (CI). 
 
To explore associations of demographics, previous clinical history and sexual 
behaviours with i) prevalent STI at baseline and ii) incident outcomes, we conducted 
univariable analyses using the Chi-squared test and log rank test, respectively. 
Individuals with missing information were not included in these analyses. Two 
variables were included for clinical history: a diagnosis of an acute STI in the 
previous year (defined as a bacterial STI and any of the following: non-gonococcal 
urethritis, and first episode of genital warts and herpes) and HIV test/STI screen. 
Variables with marginal associations (p<0.1) were included in multivariable logistic 
and Cox regression analyses, respectively. A stepwise backward approach was 
used to sequentially remove variables not significant (p>0.05) in order of the p value 
magnitude. In the final model, adjusted odds ratios (OR) or hazard ratios (HR) and 
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95%CI were reported for factors significantly associated with prevalent and incident 
infection, respectively. Multivariable analyses were only performed for the two 
bacterial STI outcomes; there were insufficient HIV incident endpoints for this 
analysis.  
 
Clinic attendees not participating in the survey 
HIV negative MSM attending a participating clinic during the study period who were 
not recruited (e.g. not offered or declined to participate in the survey) were identified 
using GUMCAD and their demographic profile and clinical history compared to MSM 
who were recruited to determine representativeness. We also examined outcomes 
among non-recruited MSM.  
 




The Medical Director of Health Protection Agency (as Public Health England was 
known in 2012), who belonged to an internal independent research office, deemed 
this work public health surveillance and therefore not requiring ethical approval. The 
information collected in the questionnaire was considered part of normal clinical 
practice and one of the aims of this study was to standardise collection of this 
information. Data linkage to GUMCAD, which is a pseudo-anonymised surveillance 






In total, 1,601 MSM were recruited and completed the questionnaire;  recruitment  was 
8% (1601/20,340) with higher completion in the clinician-led study clinic (30%). 
Overall, 22% of questionnaires were from this clinic. Of the 1,601 MSM, 1,278 (80%) 
could be linked to their clinical records in GUMCAD. The median age was 31 years, 
54% were white and UK-born and 53% attended a London clinic (Table 1).At the 
baseline attendance, 73% took a HIV test. Almost half had attended the clinic in the 
year prior to their baseline attendance of whom 96% had tested for STIs and/or HIV 
and 37% were diagnosed with an acute STI.  
 
 








Age group    
15-24 274 (21) 2,940 (15) <0.001 
25-34 546 (43) 8,150 (42)  
35-49 367 (29) 6,451 (34)  
50+ 91 (7) 1,683 (9)  
 
Ethnicity and birthplace 
 
 <0.001 
White UK-born 717 (56) 8,935 (46)  
White European 233 (18) 3,820 (20)  
White non-European 110 (9) 2,170 (11)  
Non-white UK-born 77 (6) 1,116 (6)  
Non-white born abroad 117 (9) 2,183 (11)  
Unknown 24 (2) 1,000 (5)  
 
Attendance at clinic 
 
 <0.001 
Outside London 598 (47) 2,289 (12)  



















    
 




HIV testing/STI screening  559 (96) 6,511 (89) <0.001 
Diagnosis of acute STI  213 (37) 1,609 (22) <0.001 
Total 581 7,301**  
*P value of comparison of recruited men at baseline with men not recruited 
**The first attendance date where a questionnaire could have been completed was considered the 
baseline attendance and was used to identify the prior year 
 
 
There were 19,200 MSM who were not recruited; they differed demographically and 
clinically to recruited men. Recruited men were more likely to be younger (<35 years: 
64% vs 57%, p<0.001), white and born in the UK (54% vs 46%, p<0.001) and 
diagnosed with an acute STI in the prior year (37% vs. 22%, p<0.001) than non-
recruited men (Table 1).   
 
Prevalence of sexual behaviours 
Three per cent reported no (anal or oral) partners in the last three months while 41% 
reported 2-4 and 34% more than 4 partners. The median number of total partners 
was 3 (IQR: 1-6). Fewer men at the clinician-led clinic reported five or more partners 
(20% vs. 30-43%, p<0.001). Older MSM were more likely to report five or more 
partners (42% of MSM aged 35-49 vs. 25% aged15-24, p<0.001) as were white 
MSM born in Europe compared to born in the UK (43% vs. 30%, p=0.004) (Table 2).  
 
Table 2 Overview of sexual behaviours in the last three months reported by HIV 
















Age group     
15-24 66 (25) 117 (52) 94 (39) 89 (38) 
25-34 168 (32) 258 (56) 198 (41) 204 (44) 
35-49 153 (42) 140 (47) 86 (28) 118 (39) 
50+ 32 (36) 28 (44) 19 (27) 25 (37) 
Ethnicity and 
birthplace 
    
White UK-born 209 (30) 263 (46) 206 (34) 201 (35) 
White European 97 (43) 105 (52) 79 (38) 82 (40) 
White non-
European 
41 (39) 63 (69) 37 (39) 54 (56) 
Non-white UK-
born 
23 (31) 38 (59) 25 (37) 35 (54) 
Non-white born 
abroad 
40 (35) 60 (62) 42 (40) 50 (51) 
Unknown 9 (38) 14 (67) 8 (38) 14 (64) 
Attendance at 
clinic 
    
Outside London 153 (26) 171 (41) 147 (32) 136 (31) 
London 266 (40) 372 (60) 250 (39) 300 (48) 
Total 419 (34) 543 (52) 397 (36) 436 (41) 
 
*28 (2%), 173 (14%) and 213 (17%) MSM did not report numbers of sexual partners, CRAI and CIAI 
partners, respectively 
 
Half of men reported CAI in the last three months (Table 2) with no difference in the 
clinician-led clinic compared to the others. More young MSM reported CAI (52%) 
compared to MSM aged 50+ years (44%, p=0.048) and fewer white UK born MSM 
reported CAI (46%) compared to other groups. Thirty-six per cent of men reported 
CRAI and 41% reported CIAI in the last three months and a  quarter reported last 
having CRAI in the last month. A quarter reported one CRAI and CIAI partner, 8% 
and 11% reported 2-4 CRAI and CIAI partners, respectively and the remainder 
reported more than 4 partners. A greater proportion of young MSM reported CRAI 
(15-24: 39% vs 50+: 27%, p<0.001), with no other differences by demographics or 
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previous clinical history. CRAI with a serodiscordant or unknown HIV status partner 
was reported by 18% of the sample.  
 
Prevalence of diagnosed bacterial STI at baseline, and risk factors 
Almost a quarter of men were diagnosed with a bacterial STI at baseline compared 
to 12% of non-recruited MSM (p<0.001). Bacterial STI prevalence and univariate 
analyses by sub-groups are shown in Table 3. In multivariable analyses, the odds of 
being infected at baseline was four  times higher among men reporting >4 partners 
and twice as high among those reporting CRAI with 2-4 partners compared to those 
reporting no CRAI. 
 
Table 3 Bacterial STI prevalence and incidence with associated risk factors among 




 Prevalence of and risk factors for bacterial STIs, n=1,278 Incidence of and risk factors for bacterial STIs, n=628 






P value Number of 
infections (%) 
Incidence/100 






Age group          
15-24 67 (4) 1 n.s. n.s. 39 (27) 63.2 (46.2-86.4) 1 n.s. n.s. 
25-34 155 (28) 1.2 (0.9-1.7) n.s.  65 (23) 44.8 (35.2-57.1) 0.7 (0.5-1.0) n.s.  
35-49 71 (19) 0.7 (0.5-1.1) n.s.  35 (20) 38.4 (27.5-53.4) 0.6 (0.4-0.9) n.s.  
50+ 12 (13) 0.5 (0.2-0.9) n.s.  5 (18) 36.2 (15.1-87.0) 0.6 (0.2-1.4) n.s.  
Ethnicity and birthplace          
White UK-born 176 (25) 1 n.a. - 74 (24) 51.6 (41.1-64.8) 1 n.a. - 
White European 59 (25) 1.0 (0.7-1.5) n.a.  26 (19) 35.2 (24.0-51.7) 0.7 (0.4-1.1) n.a.  
White non-European 24 (22) 0.9 (0.5-1.4) n.a.  20 (30) 54.6 (35.2-84.6) 1.0 (0.6-1.7) n.a.  
Non-white UK-born 14 (18) 0.7 (0.4-1.2) n.a.  9 (22) 38.7 (20.2-74.5) 0.7 (0.4-1.5) n.a.  
Non-white born abroad 25 (21) 0.8 (0.5-1.3) n.a.  12 (18) 40.9 (23.2-72.0) 0.8 (0.4-1.5) n.a.  
Attending a London clinic          
No 149 (25) 1 n.a - 51 (24) 69.0 (52.4-90.8) 1 1 <0.002 
Yes 156 (23) 0.9 (0.7-1.2) n.a  93 (22) 39.1 (31.9-47.9) 0.5 (0.3-0.7) 0.5 (0.4-0.8).  
HIV test/STI screen last year          
Attended, no test 4 (18) 1 n.a. - 2 (18) 27.8 (7.0-111.2) 1 n.a. - 
Attended, test 127 (23) 1.3 (0.4-4.0) n.a.  88 (25) 48.0 (39.0-59.2) 1.7 (0.4-7.0) n.a.  
Did not attend  174 (25) 1.5 (0.5-4.5) n.a.  54 (21) 44.5 (34.1-58.1) 1.6 (0.4-6.8) n.a.  
Acute STI last year          
Attended, no STI 80 (22) 1 n.a. - 42 (18) 32.8 (24.2-44.3) 1 1 0.02 
Attended, STI 51 (24) 1.1 (0.8-1.7) n.a.  48 (36) 77.2 (58.1-102.4) 2.4 (1.6-3.6) 1.9 (1.2-3.0)  
Did not attend  174 (25) 1.2 (0.9-1.6) n.a.  54 (21) 44.5 (34.1-58.1) 1.4 (0.9-2.1) 1.3 (0.9-2.0)  
Sexual partners          
0 3 (8) 1 1 0.006 25 (22) 49.6 (33.5-73.4) 1 n.s. n.s. 
1 48 (17) 2.5 (0.7-8.5) 2.1 (0.6-7.2)  37 (16) 31.1 (22.5-42.9) 0.6 (0.4-1.1) n.s.  
2-4 120 (23) 3.6 (1.1-12.0) 3.0 (0.9-10.0)  44 (25) 50.0 (37.2-67.1) 1.0 (0.6-1.7) n.s.  
>4 126 (30) 5.2 (1.6-17.1) 4.0 (1.2-13.5))  33 (42) 81.7 (58.1-114.9) 1.7 (1.0-2.9) n.s.  
CRAI with no. of partners          
0 151 (20) 1 1 0.006 71 (20) 40.7 (32.2-51.3) 1 1 0.03 
1 81 (28) 1.6 (1.2-2.2) 1.6 (1.1-2.2)  33 (22) 40.7 (28.9-57.2) 1.0 (0.6-1.5) 1.0 (0.7-1.5)  
2-4 30 (34) 2.1 (1.3-3.4) 1.8 (1.1-2.9)  20 (40) 76.8 (49.5-119.0) 1.9 (1.1-3.1) 1.7 (1.0-2.8)  
>4 8 (32) 1.9 (0.8-4.5) 1.4 (0.6-3.4)  6 (46) 100.2 (45.0-223.0) 2.6 (1.1-6.0) 2.5 (1.1-6.0)  
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CIAI with no. of partners          
0 137 (20) 1 n.s. n.s. 61 (19) 37.4 (29.1-48.1) 1 n.s. n.s. 
1 70 (25) 1.3 (0.9-1.8) n.s.  38 (28) 57.8 (42.1-79.5) 1.6 (1.1-2.4) n.s.  
2-4 37 (33) 1.9 (1.2-2.9) n.s.  15 (22) 39.2 (23.6-65.0) 1.0 (0.6-1.8) n.s.  
>4 14 (31) 1.8 (0.9-3.4) n.s.  10 (42) 85.4 (46.0-158.8) 2.3 (1.2-4.4) n.s.  
Bacterial STI at baseline          
No - - - - 89 (18) 36.5 (29.7-45.0) 1 1 <0.001 
Yes - - -  55 (36) 80.7 (62.0-105.1) 2.2 (1.6-3.1) 2.2 (1.5-3.2)  
Total 305    144 46.2 (39.2-54.4)    
n.s.: not significant where variables had p<0.1 in univariate analyses but p>0.05 in multivariable analyses 
n.a.: not applicable. Only values with p<0.1 included in multivariable analyses
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Incidence of bacterial STIs and risk factors 
There were 628 MSM who re-attended the same clinic after the baseline 
attendance; average follow-up time was 185 (standard deviation: 106) and 234 (SD: 
114) days among those with and without the outcome, respectively.  There were 144 
new diagnoses of bacterial STIs during 311 person-years of follow-up, which 
equated to an incidence of 46.2/100 py (95%CI 39.3-54.4). In comparison, incidence 
was 18.6/100 py (17.9-19.3) among non-recruited MSM. Bacterial STI incidence was 
highest among MSM reporting more than four CRAI (100/100 py) and CIAI (85/100 
py) partners (Table 3). In multivariable analyses, MSM diagnosed with a bacterial 
STI at baseline were twice as likely to be diagnosed with an incident bacterial STI in 
the subsequent year (same or different STI as at baseline) (Table 3). Numbers of 
CRAI partners was associated with subsequent STI incidence. Men reporting >4 
partners were two and a half times more likely to acquire a bacterial STI (95%CI 1.1-
6.0).  
 
HIV incidence and associated risk factors 
Average follow-up time was 186 (SD: 136) and 246 (SD:116) days among those with 
and without a HIV diagnosis, respectively. There were 11 incident HIV diagnoses; 
total person time was 356 years and HIV incidence was 3.1/100 py (95%CI 1.7-5.6) 
(Table 4). In comparison, among 13,282 non-recruited MSM who re-attended the 
clinic, 83 new HIV infections were detected and HIV incidence was 0.5/100 py (0.4-
0.5). In univariate analyses, men reporting CRAI with more than one partner were 
four times more likely to acquire HIV than those reporting none or one partner 
(unadjusted HR: 4.2 95%CI 1.0-17.6) and those diagnosed with a baseline bacterial 




Table 4 HIV incidence and unadjusted hazard ratios among HIV negative MSM by 
demographics and clinical history, England, 2012-2013 








Age group    
15-29 7 (1.9) 4.4 (2.2-9.2) 1 
30+ 4 (1.2) 2.0 (0.8-5.4) 0.5 (0.2-1.9) 
Ethnicity and birthplace    
White UK-born 6 (1.9) 3.6  (1.6-8.1) 1 
Other 5 (1.6) 2.7 (1.1-6.5) 0.9 (0.3-3.2) 
Attending a London clinic    
No 3 (1.4) 3.6 (1.1-11.0) 1 
Yes 8 (1.9) 2.9 (1.5-5.9) 0.8 (0.2-3.1) 
Acute STI last year    
Attended, no STI 2 (0.8) 1.4 (0.4-5.6) 1 
Attended, STI 6 (4.4) 7.5 (3.4-16.7) 4.4 (0.8-22.4) 
Did not attend  3 (1.1)  2.3 (0.7-7.0) 1.6 (0.3-9.4) 
Bacterial STI at baseline    
No  6 (1.2) 2.2 (1.0-5.0) 1 
Yes 5 (3.1) 5.8 (2.4-13.8) 3.0 (1.0-10.5) 
Sexual partners    
0-1 2 (1.6) 3.3 (0.8-13.1) 1 
≥2 9 (1.8) 3.2 (1.7-6.1) 2.0 (0.2-15.6) 
CRAI with no. of partners    
0-1 6 (1.2) 2.0  (0.9-4.7) 1 
≥2 3 (4.7) 7.3 (2.4-22.7) 4.2 (1.0-17.6) 
CIAI with no. of partners    
0-1 8 (1.7) 3.1 (1.6-6.3) 1 
≥2 1 (1.1) 1.6 (0.2-11.5) 0.6 (0.08-5.0) 
Total 11   
 
DISCUSSION  
Our study uniquely provides sexual behavioural information for an open cohort of 
HIV negative MSM in England who were followed-up to determine their clinical 
outcomes. MSM attending clinics had a high burden of STI and reported high levels 
of risk behaviours with over a third reporting CRAI. Men diagnosed with a STI at 
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baseline were twice as likely to be diagnosed with another STI within a year 
highlighting ongoing risk in this population.   
 
The prevalence of sexual behaviours reported in our clinic-based study were 
comparable to a recent clinic study of MSM, which reported 58% of HIV negative 
MSM had condomless sex and 13% had engaged in CRAI with a sexual partner of 
unknown or HIV positive status in the last three months (15). Sexual risk behaviours 
in our study was, however, higher than those reported from a nationally 
representative sample of MSM (16). These data further confirm that MSM attending 
SH clinics engage in high risk sexual behaviours that could also be linked to other 
risk behaviours including drug use (15). 
 
Bacterial STI incidence was extremely high in our sample and of greater concern, we 
found men diagnosed at baseline were significantly more likely to be diagnosed with 
another STI within a year. Recent literature on incidence of new infections among 
MSM is limited with only one study in England reporting high incidence of new 
infections among those with a previous bacterial infection (17). There were no 
changes in testing strategy during the study that might explain the high incidence 
and it is likely our findings highlight on-going risk in this sub-population despite 
recent contact with SH services. MSM are recommended to test for STIs at all 
anatomical sites annually and three-monthly if at high risk (18). Practice, however, 
differs between clinics and information on the extent of site-specific testing was not 
available to the investigators. Baseline bacterial STIs were also a risk factor for 
incident HIV infection; bacterial STIs, especially gonorrhoea, are known predictors 
for HIV infection (5, 19).  These findings argue for more frequent STI and HIV testing 
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among MSM diagnosed with bacterial STIs to identify infections earlier and 
prevention onward transmission.  
HIV incidence in our cohort was higher than other available estimates for MSM 
attending SH clinics in England (5, 20) with the upper confidence estimate 
suggesting true incidence could be two to three times higher and which would reflect 
the high risk behaviours reported by the recruited sample. Our point estimate is 
similar to cohorts of MSM in Spain (21) and the US (22) but higher than in Australia 
(1.3/100 py) (23). The group of men reporting engaging in CRAI with partners of 
unknown or serodiscordant HIV status may not necessarily be employing any risk 
reduction strategies such as seroadaptation. Further, we found increasing numbers 
of partners with whom men engaged in CRAI with was significantly associated with 
increased risk of HIV and STI infection. Some of these could be men actively 
serosorting but successful seroadaptation requires knowledge of the partner’s HIV 
status and with one in eight MSM living with HIV in the UK unaware of their infection 
(1) and inadequate levels of HIV testing (8, 24), men are more likely to be 
“seroguessing” rather than serosorting (25). Engagement in condomless sex 
increases the risk of transmitting and acquiring STIs and STI rates have shown to be 
higher among those assuming seroconcordance (11). Although studies have shown 
seroadaptive behaviours are better for HIV prevention than employing no strategy 
(26, 27), they still represent a significantly increased risk of acquiring an infection.  
 
The observed high risk in this population stresses the need for HIV and STI 
prevention interventions for MSM attending clinics. In resource limited settings, the 
objective calculation of an individual’s risk based on key characteristics and 
behaviours could assist clinical decision making and prioritisation of service delivery. 
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Triaging in clinical practice is becoming increasingly important and has recently been 
used in the US to aid clinicians in offering HIV prevention services that are tailored to 
an individual’s risk (28, 29) and for determining gonorrhoea and chlamydia screening 
thresholds (30).  
 
A similar approach could be taken in SH clinics in England whereby a risk 
assessment tool could inform an individual’s current risk of HIV or a STI and assess 
an individual’s need for intensified prevention services including, but not limited to, 
frequent HIV testing and STI screening, behavioural interventions and prescription of 
pre-exposure prophylaxis (PrEP), which was  found to be highly effective at 
preventing HIV acquisition among MSM (31).  The recent implementation of the 
IMPACT trial to deliver PrEP to 10,000 people in England is an important step 
forward for HIV prevention. However, it will be necessary to monitor the impact of 
taking PrEP on sexual behaviour and STI acquisition given the evidence showing 
that both might increase when on PrEP (32). Dean Street, a London SH clinic, also 
recently launched Dean Street Prime a service offered to high risk MSM identified 
using recent clinical outcomes and sexual behaviours (http://prime.dean.st/). By 
offering five programmes, it demonstrates how services can be designed and 
individually tailored to allow men to take control of their sexual health. 
 
There are several limitations to this study. First, the study only achieved 8% 
recruitment (clinic range: 5%-33%), as the questionnaires were not consistently 
offered to men due to operational difficulties including other competing studies, large 
workloads and clinic staff forgetting. We were also unable to measure the proportion 
that were asked to complete the survey and declined. Recruitment may have 
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improved with a dedicated researcher in each clinic or alternative delivery 
mechanisms such as placing the questionnaire in all men’s folders, which may have 
reminded staff of the survey. The recruited sample was not representative of MSM 
attendees at the five clinics; participants were younger, white UK born and were 
potentially higher risk. Reported results are likely to overestimate high risk 
behaviours and incidence estimates in the wider MSM population.  
 
Second, prospective analyses had to be restricted to men who returned to the same 
clinic because GUMCAD can only be used to follow individuals within clinics. 
Movement between clinics is likely to be common in urban areas where the 
availability of more SH clinics provides greater clinic choice (33). It is therefore 
possible men attended and were diagnosed with subsequent STI or HIV elsewhere, 
and which could not be identified through the study. An underestimation of the 
number of infections will underestimate incidence in the cohort.  
 
Third, reason for attendance is not collected in GUMCAD and for some men 
attendance may be related to risk. By only following individuals for one year those at 
risk are more likely to return in a shorter period of time and are thus favoured for 
selection in the cohort compared to MSM at lower risk (e.g. routine check-up). Our 
estimates potentially pertain to a cohort of MSM who are higher risk and among 
whom incidence is higher than in other MSM attending SH clinics. However, our 
interest lies in this population because most HIV diagnoses are likely to occur among 




Finally, the study relied on self-reported sexual behaviours and HIV status of 
partners. Social desirability bias could result in under-reporting of CAI and dilute the 
role of behaviours on incident infection. The effects may be different between men 
self-completing the questionnaire and those completing it with staff. Men may under-
report risky behaviours to staff. However, cognitive testing of the questionnaire 
suggested men were accustomed to providing sexual behavioural information at SH 
clinics and did not think they would respond differently between the two methods. 
 
Our study adds to the evidence base that MSM attending SH clinics report high risk 
sexual behaviours and a high burden of STI. Despite potential exposure to 
prevention services at clinics, men diagnosed with a STI at baseline are at increased 
risk of coming back with another STI. Employment of clinical and behavioural risk 
triaging of MSM could objectively ascertain an individual’s risk of infection and allow 
a more nuanced and tailored prevention approach that has greater success in 
reducing transmission.  
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